Abstract
Adipocytes are crucial components of breast cancer and are involved in regulating the progression, therapeutic efficacy, and prognosis of breast cancer patients. Characterized by storing energy and producing a variety of secretory factors, adipocytes are responsible for inducing obesity and regulating the tumor immune activity. Adipocytes communicate with tumor infiltrating immune cells through the secreted adipokines, cytokines, and exosomes in the breast cancer TIME, which shapes the tumor supporting environment to facilitate the immune escape of tumor cells. In-depth studies of the crosstalk between adipocytes and TIME can not only provide a more comprehensive regulatory landscape of TIME, but also be conducive to screening novel targets for future precision targeted therapy. The aim of this review is to discuss recent studies for understanding the role of crosstalk between adipocytes and immune cells in shaping the breast cancer immune microenvironment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable.
References
Al-Khalaf HH, Al-Harbi B, Al-Sayed A, Arafah M, Tulbah A, Jarman A et al (2019) Interleukin-8 activates breast cancer-associated adipocytes and promotes their angiogenesis- and tumorigenesis-promoting effects. Mol Cell Biol. https://doi.org/10.1128/MCB.00332-18
Almekinders MMM, Schaapveld M, Thijssen B, Visser LL, Bismeijer T, Sanders J et al (2021) Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ. NPJ Breast Cancer 7(1):31. https://doi.org/10.1038/s41523-021-00232-w
Arendt LM, McCready J, Keller PJ, Baker DD, Naber SP, Seewaldt V et al (2013) Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Res 73(19):6080–6093. https://doi.org/10.1158/0008-5472.CAN-13-0926
Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541–550. https://doi.org/10.1038/s41591-018-0014-x
Bochet L, Lehuede C, Dauvillier S, Wang YY, Dirat B, Laurent V et al (2013) Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. Cancer Res 73(18):5657–5668. https://doi.org/10.1158/0008-5472.CAN-13-0530
Buonaiuto R, Napolitano F, Parola S, De Placido P, Forestieri V, Pecoraro G et al (2022) Insight on the role of leptin: a bridge from obesity to breast cancer. Biomolecules. https://doi.org/10.3390/biom12101394
Cha YJ, Kim ES, Koo JS (2018) Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer. Breast Cancer Res Treat 170(1):15–25. https://doi.org/10.1007/s10549-018-4722-1
Chang MC, Eslami Z, Ennis M, Goodwin PJ (2021) Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis. NPJ Breast Cancer 7(1):97. https://doi.org/10.1038/s41523-021-00304-x
Cho KW, Morris DL, DelProposto JL, Geletka L, Zamarron B, Martinez-Santibanez G et al (2014) An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation. Cell Rep 9(2):605–617. https://doi.org/10.1016/j.celrep.2014.09.004
Choi J, Cha YJ, Koo JS (2018) Adipocyte biology in breast cancer: From silent bystander to active facilitator. Prog Lipid Res 69:11–20. https://doi.org/10.1016/j.plipres.2017.11.002
Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46(11):2347–2355. https://doi.org/10.1194/jlr.M500294-JLR200
Colleluori G, Perugini J, Barbatelli G, Cinti S (2021) Mammary gland adipocytes in lactation cycle, obesity and breast cancer. Rev Endocr Metab Disord 22(2):241–255. https://doi.org/10.1007/s11154-021-09633-5
Cote JA, Lessard J, Pelletier M, Marceau S, Lescelleur O, Fradette J et al (2017) Role of the TGF-beta pathway in dedifferentiation of human mature adipocytes. FEBS Open Bio 7(8):1092–1101. https://doi.org/10.1002/2211-5463.12250
Deepak KGK, Vempati R, Nagaraju GP, Dasari VR, S, N., Rao, D. N., et al (2020) Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol Res 153:104683. https://doi.org/10.1016/j.phrs.2020.104683
Delort L, Rossary A, Farges MC, Vasson MP, Caldefie-Chezet F (2015) Leptin, adipocytes and breast cancer: focus on inflammation and anti-tumor immunity. Life Sci 140:37–48. https://doi.org/10.1016/j.lfs.2015.04.012
Deng T, Lyon CJ, Minze LJ, Lin J, Zou J, Liu JZ et al (2013) Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 17(3):411–422. https://doi.org/10.1016/j.cmet.2013.02.009
Dieci MV, Miglietta F, Guarneri V (2021) Immune infiltrates in breast cancer: recent updates and clinical implications. Cells. https://doi.org/10.3390/cells10020223
Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B et al (2011) Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71(7):2455–2465. https://doi.org/10.1158/0008-5472.CAN-10-3323
Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22:329–360. https://doi.org/10.1146/annurev.immunol.22.012703.104803
Engin AB, Engin A, Gonul II (2019) The effect of adipocyte-macrophage crosstalk in obesity-related breast cancer. J Mol Endocrinol 62(3):R201–R222. https://doi.org/10.1530/JME-18-0252
Fletcher SJ, Sacca PA, Pistone-Creydt M, Colo FA, Serra MF, Santino FE et al (2017) Human breast adipose tissue: characterization of factors that change during tumor progression in human breast cancer. J Exp Clin Cancer Res 36(1):26. https://doi.org/10.1186/s13046-017-0494-4
Fu T, Dai LJ, Wu SY, Xiao Y, Ma D, Jiang YZ et al (2021) Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J Hematol Oncol 14(1):98. https://doi.org/10.1186/s13045-021-01103-4
Gonzalez RR, Leavis PC (2003) A peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells. Endocrine 21(2):185–195. https://doi.org/10.1385/ENDO:21:2:185
Gustafson B, Smith U (2010) Activation of canonical wingless-type MMTV integration site family (Wnt) signaling in mature adipocytes increases beta-catenin levels and leads to cell dedifferentiation and insulin resistance. J Biol Chem 285(18):14031–14041. https://doi.org/10.1074/jbc.M110.102855
Harmon T, Harbuzariu A, Lanier V, Lipsey CC, Kirlin W, Yang L et al (2017) Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer. World J Clin Oncol 8(1):54–66. https://doi.org/10.5306/wjco.v8.i1.54
He JY, Wei XH, Li SJ, Liu Y, Hu HL, Li ZZ et al (2018) Adipocyte-derived IL-6 and leptin promote breast cancer metastasis via upregulation of lysyl hydroxylase-2 expression. Cell Commun Signal 16(1):100. https://doi.org/10.1186/s12964-018-0309-z
Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA (2016) Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol 34(35):4270–4276. https://doi.org/10.1200/JCO.2016.67.4283
Jafari N, Kolla M, Meshulam T, Shafran JS, Qiu Y, Casey AN et al (2021) Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes. Sci Signal. https://doi.org/10.1126/scisignal.abj2807
Jo J, Guo J, Liu T, Mullen S, Hall KD, Cushman SW et al (2010) Hypertrophy-driven adipocyte death overwhelms recruitment under prolonged weight gain. Biophys J 99(11):3535–3544. https://doi.org/10.1016/j.bpj.2010.10.009
Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I et al (2010) Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Am J Pathol 176(4):2019–2028. https://doi.org/10.2353/ajpath.2010.090908
Julia EP, Amante A, Pampena MB, Mordoh J, Levy EM (2018) Avelumab, an IgG1 anti-PD-L1 immune checkpoint inhibitor, triggers NK cell-mediated cytotoxicity and cytokine production against triple negative breast cancer cells. Front Immunol 9:2140. https://doi.org/10.3389/fimmu.2018.02140
Kennedy DE, Knight KL (2015) Inhibition of B lymphopoiesis by adipocytes and IL-1-producing myeloid-derived suppressor cells. J Immunol 195(6):2666–2674. https://doi.org/10.4049/jimmunol.1500957
Kim MY, Kim DH, Do MS (2013) B-cell-activating factor is a regulator of adipokines and a possible mediator between adipocytes and macrophages. Exp Mol Med 45(1):e4. https://doi.org/10.1038/emm.2013.4
Kim HS, Jung M, Choi SK, Woo J, Piao YJ, Hwang EH et al (2018) IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression. J Exp Clin Cancer Res 37(1):200. https://doi.org/10.1186/s13046-018-0867-3
Kolb R, Phan L, Borcherding N, Liu Y, Yuan F, Janowski AM et al (2016) Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nat Commun 7:13007. https://doi.org/10.1038/ncomms13007
Kothari C, Diorio C, Durocher F (2020) The importance of breast adipose tissue in breast cancer. Int J Mol Sci. https://doi.org/10.3390/ijms21165760
Laforest S, Ennour-Idrissi K, Ouellette G, Gauthier MF, Michaud A, Durocher F et al (2021) Associations between markers of mammary adipose tissue dysfunction and breast cancer prognostic factors. Int J Obes (lond) 45(1):195–205. https://doi.org/10.1038/s41366-020-00676-3
Lamas B, Nachat-Kappes R, Goncalves-Mendes N, Mishellany F, Rossary A, Vasson MP et al (2015) Dietary fat without body weight gain increases in vivo MCF-7 human breast cancer cell growth and decreases natural killer cell cytotoxicity. Mol Carcinog 54(1):58–71. https://doi.org/10.1002/mc.22074
Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56(20):4625–9. https://www.ncbi.nlm.nih.gov/pubmed/8840975.
Liou YH, Wang SW, Chang CL, Huang PL, Hou MS, Lai YG et al (2014) Adipocyte IL-15 regulates local and systemic NK cell development. J Immunol 193(4):1747–1758. https://doi.org/10.4049/jimmunol.1400868
Liu Y, Tiruthani K, Wang M, Zhou X, Qiu N, Xiong Y et al (2021) Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancer. Nanoscale Horiz 6(4):319–329. https://doi.org/10.1039/d0nh00588f
Liu S, Wang L, Ling D, Valencak TG, You W, Shan T (2022) Potential key factors involved in regulating adipocyte dedifferentiation. J Cell Physiol 237(3):1639–1647. https://doi.org/10.1002/jcp.30637
Macis D, Guerrieri-Gonzaga A, Gandini S (2014) Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis. Int J Epidemiol 43(4):1226–1236. https://doi.org/10.1093/ije/dyu088
Maliniak ML, Miller-Kleinhenz J, Cronin-Fenton DP, Lash TL, Gogineni K, Janssen EAM et al (2021) Crown-like structures in breast adipose tissue: early evidence and current issues in breast cancer. Cancers (Basel). https://doi.org/10.3390/cancers13092222
Matas-Rico E, Frijlink E, van der Haar Avila I, Menegakis A, van Zon M, Morris AJ et al (2021) Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8(+) T cells. Cell Rep 37(7):110013. https://doi.org/10.1016/j.celrep.2021.110013
Maurizi G, Della Guardia L, Maurizi A, Poloni A (2018) Adipocytes properties and crosstalk with immune system in obesity-related inflammation. J Cell Physiol 233(1):88–97. https://doi.org/10.1002/jcp.25855
Mehta AK, Kadel S, Townsend MG, Oliwa M, Guerriero JL (2021) Macrophage biology and mechanisms of immune suppression in breast cancer. Front Immunol 12:643771. https://doi.org/10.3389/fimmu.2021.643771
Mentoor I, Engelbrecht AM, van Jaarsveld PJ, Nell T (2018) Chemoresistance: intricate interplay between breast tumor cells and adipocytes in the tumor microenvironment. Front Endocrinol (lausanne) 9:758. https://doi.org/10.3389/fendo.2018.00758
Munir MT, Kay MK, Kang MH, Rahman MM, Al-Harrasi A, Choudhury M et al (2021) Tumor-associated macrophages as multifaceted regulators of breast tumor growth. Int J Mol Sci. https://doi.org/10.3390/ijms22126526
Murano I, Barbatelli G, Parisani V, Latini C, Muzzonigro G, Castellucci M et al (2008) Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res 49(7):1562–1568. https://doi.org/10.1194/jlr.M800019-JLR200
Na H, Song Y, Lee HW (2023) Emphasis on adipocyte transformation: anti-inflammatory agents to prevent the development of cancer-associated adipocytes. Cancers (Basel). https://doi.org/10.3390/cancers15020502
Nakamura K, Smyth MJ (2020) Myeloid immunosuppression and immune checkpoints in the tumor microenvironment. Cell Mol Immunol 17(1):1–12. https://doi.org/10.1038/s41423-019-0306-1
Ni Y, Zhou X, Yang J, Shi H, Li H, Zhao X et al (2021) The role of tumor-stroma interactions in drug resistance within tumor microenvironment. Front Cell Dev Biol 9:637675. https://doi.org/10.3389/fcell.2021.637675
Otvos L Jr, Haspinger E, La Russa F, Maspero F, Graziano P, Kovalszky I et al (2011a) Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol 11:90. https://doi.org/10.1186/1472-6750-11-90
Otvos L Jr, Kovalszky I, Riolfi M, Ferla R, Olah J, Sztodola A et al (2011b) Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur J Cancer 47(10):1578–1584. https://doi.org/10.1016/j.ejca.2011.01.018
Otvos L Jr, Kovalszky I, Olah J, Coroniti R, Knappe D, Nollmann FI et al (2015) Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling. Biopolymers 104(3):156–166. https://doi.org/10.1002/bip.22627
Pare M, Darini CY, Yao X, Chignon-Sicard B, Rekima S, Lachambre S et al (2020) Breast cancer mammospheres secrete Adrenomedullin to induce lipolysis and browning of adjacent adipocytes. BMC Cancer 20(1):784. https://doi.org/10.1186/s12885-020-07273-7
Parkin J, Cohen B (2001) An overview of the immune system. Lancet 357(9270):1777–1789. https://doi.org/10.1016/S0140-6736(00)04904-7
Peng J, Hu Q, Chen X, Wang C, Zhang J, Ren X et al (2021) Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells. Cell Death Dis 12(10):946. https://doi.org/10.1038/s41419-021-04217-2
Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM (2017) Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. CA Cancer J Clin 67(5):378–397. https://doi.org/10.3322/caac.21405
Pingili AK, Chaib M, Sipe LM, Miller EJ, Teng B, Sharma R et al (2021) Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer. Cell Rep 35(12):109285. https://doi.org/10.1016/j.celrep.2021.109285
Qian F, Qingping Y, Linquan W, Xiaojin H, Rongshou W, Shanshan R et al (2017) High tumor-infiltrating FoxP3(+) T cells predict poor survival in estrogen receptor-positive breast cancer: a meta-analysis. Eur J Surg Oncol 43(7):1258–1264. https://doi.org/10.1016/j.ejso.2017.01.011
Ramsay DT, Kent JC, Hartmann RA, Hartmann PE (2005) Anatomy of the lactating human breast redefined with ultrasound imaging. J Anat 206(6):525–534. https://doi.org/10.1111/j.1469-7580.2005.00417.x
Rene Gonzalez R, Watters A, Xu Y, Singh UP, Mann DR, Rueda BR et al (2009) Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res 11(3):R36. https://doi.org/10.1186/bcr2321
Ringel AE, Drijvers JM, Baker GJ, Catozzi A, Garcia-Canaveras JC, Gassaway BM et al (2020) Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell 183(7):1848-1866 e26. https://doi.org/10.1016/j.cell.2020.11.009
Rybinska I, Mangano N, Tagliabue E, Triulzi T (2021) Cancer-associated adipocytes in breast cancer: causes and consequences. Int J Mol Sci. https://doi.org/10.3390/ijms22073775
Sarantopoulos CN, Banyard DA, Ziegler ME, Sun B, Shaterian A, Widgerow AD (2018) Elucidating the preadipocyte and its role in adipocyte formation: a comprehensive review. Stem Cell Rev Rep 14(1):27–42. https://doi.org/10.1007/s12015-017-9774-9
Schupp M, Cristancho AG, Lefterova MI, Hanniman EA, Briggs ER, Steger DJ et al (2009) Re-expression of GATA2 cooperates with peroxisome proliferator-activated receptor-gamma depletion to revert the adipocyte phenotype. J Biol Chem 284(14):9458–9464. https://doi.org/10.1074/jbc.M809498200
Shou J, Zhang Z, Lai Y, Chen Z, Huang J (2016) Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis. BMC Cancer 16(1):687. https://doi.org/10.1186/s12885-016-2732-0
Smas CM, Chen L, Sul HS (1997) Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation. Mol Cell Biol 17(2):977–988. https://doi.org/10.1128/MCB.17.2.977
Song J, Deng T (2020) The adipocyte and adaptive immunity. Front Immunol 11:593058. https://doi.org/10.3389/fimmu.2020.593058
Stenkula KG, Erlanson-Albertsson C (2018) Adipose cell size: importance in health and disease. Am J Physiol Regul Integr Comp Physiol 315(2):R284–R295. https://doi.org/10.1152/ajpregu.00257.2017
Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK et al (2011) Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (phila) 4(3):329–346. https://doi.org/10.1158/1940-6207.CAPR-10-0381
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
Surmacz E (2013) Leptin and adiponectin: emerging therapeutic targets in breast cancer. J Mammary Gland Biol Neoplasia 18(3–4):321–332. https://doi.org/10.1007/s10911-013-9302-8
Tang X (2013) Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett 332(1):3–10. https://doi.org/10.1016/j.canlet.2013.01.024
Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T (2021) Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct Target Ther 6(1):72. https://doi.org/10.1038/s41392-020-00449-4
Vandeweyer E, Hertens D (2002) Quantification of glands and fat in breast tissue: an experimental determination. Ann Anat 184(2):181–184. https://doi.org/10.1016/S0940-9602(02)80016-4
Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ (2011) Natural innate and adaptive immunity to cancer. Annu Rev Immunol 29:235–271. https://doi.org/10.1146/annurev-immunol-031210-101324
Wagner J, Rapsomaniki MA, Chevrier S, Anzeneder T, Langwieder C, Dykgers A et al (2019) A single-cell atlas of the tumor and immune ecosystem of human breast cancer. Cell 177(5):1330–1345. https://doi.org/10.1016/j.cell.2019.03.005
Wang YY, Attane C, Milhas D, Dirat B, Dauvillier S, Guerard A et al (2017) Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. JCI Insight 2(4):e87489. https://doi.org/10.1172/jci.insight.87489
Wang T, Fahrmann JF, Lee H, Li YJ, Tripathi SC, Yue C et al (2018) JAK/STAT3-regulated fatty acid beta-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab 27(1):136-150 e5. https://doi.org/10.1016/j.cmet.2017.11.001
Wang YY, Hung AC, Lo S, Yuan SF (2021) Adipocytokines visfatin and resistin in breast cancer: Clinical relevance, biological mechanisms, and therapeutic potential. Cancer Lett 498:229–239. https://doi.org/10.1016/j.canlet.2020.10.045
Wu Q, Li B, Li Z, Li J, Sun S, Sun S (2019) Cancer-associated adipocytes: key players in breast cancer progression. J Hematol Oncol 12(1):95. https://doi.org/10.1186/s13045-019-0778-6
Wu Y, Yi M, Niu M, Mei Q, Wu K (2022) Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol Cancer 21(1):184. https://doi.org/10.1186/s12943-022-01657-y
Wu B, Sun X, Gupta HB, Yuan B, Li J, Ge F et al (2018) Adipose PD-L1 modulates PD-1/PD-L1 checkpoint blockade immunotherapy efficacy in breast cancer. Oncoimmunology 7(11):e1500107. https://doi.org/10.1080/2162402X.2018.1500107
Xiao L, Yang X, Lin Y, Li S, Jiang J, Qian S et al (2016) Large adipocytes function as antigen-presenting cells to activate CD4(+) T cells via upregulating MHCII in obesity. Int J Obes (lond) 40(1):112–120. https://doi.org/10.1038/ijo.2015.145
Xiao R, Mansour AG, Huang W, Chrislip LA, Wilkins RK, Queen NJ et al (2019) Adipocytes: a novel target for IL-15/IL-15Ralpha cancer gene therapy. Mol Ther 27(5):922–932. https://doi.org/10.1016/j.ymthe.2019.02.011
Xiao Y, Yu D (2021) Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 221:107753. https://doi.org/10.1016/j.pharmthera.2020.107753
Yadav NVS, Barcikowski A, Uehana Y, Jacobs AT, Connelly L (2020) Breast adipocyte co-culture increases the expression of pro-angiogenic factors in macrophages. Front Oncol 10:454. https://doi.org/10.3389/fonc.2020.00454
Yu M, Pan H, Che N, Li L, Wang C, Wang Y et al (2021) Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells. Cell Mol Immunol 18(9):2153–2164. https://doi.org/10.1038/s41423-020-0449-0
Zhang Z, Shao M, Hepler C, Zi Z, Zhao S, An YA et al (2019) Dermal adipose tissue has high plasticity and undergoes reversible dedifferentiation in mice. J Clin Invest 129(12):5327–5342. https://doi.org/10.1172/JCI130239
Zhang F, Liu S (2020) Mechanistic insights of adipocyte metabolism in regulating breast cancer progression. Pharmacol Res 155:104741. https://doi.org/10.1016/j.phrs.2020.104741
Zhang C, Yue C, Herrmann A, Song J, Egelston C, Wang T et al (2020) STAT3 activation-induced fatty acid oxidation in CD8(+) T effector cells is critical for obesity-promoted breast tumor growth. Cell Metab 31(1):148-161 e5. https://doi.org/10.1016/j.cmet.2019.10.013
Zhao Y, Sun R, You L, Gao C, Tian Z (2003) Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun 300(2):247–252. https://doi.org/10.1016/s0006-291x(02)02838-3
Zhao C, Wu M, Zeng N, Xiong M, Hu W, Lv W et al (2020) Cancer-associated adipocytes: emerging supporters in breast cancer. J Exp Clin Cancer Res 39(1):156. https://doi.org/10.1186/s13046-020-01666-z
Zhou C, He X, Tong C, Li H, Xie C, Wu Y et al (2022) Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF/CXCLs positive feedback loop. Int J Biol Sci 18(4):1363–1380. https://doi.org/10.7150/ijbs.65227
Zhu Z, Zhu X, Yang S, Guo Z, Li K, Ren C et al (2020) Yin-yang effect of tumour cells in breast cancer: from mechanism of crosstalk between tumour-associated macrophages and cancer-associated adipocytes. Am J Cancer Res 10(2):383–392. https://www.ncbi.nlm.nih.gov/pubmed/32195015
Zwick RK, Guerrero-Juarez CF, Horsley V, Plikus MV (2018a) Anatomical, physiological, and functional diversity of adipose tissue. Cell Metab 27(1):68–83. https://doi.org/10.1016/j.cmet.2017.12.002
Zwick RK, Rudolph MC, Shook BA, Holtrup B, Roth E, Lei V et al (2018b) Adipocyte hypertrophy and lipid dynamics underlie mammary gland remodeling after lactation. Nat Commun 9(1):3592. https://doi.org/10.1038/s41467-018-05911-0
Funding
This study was supported by National Natural Science Foundation of China (No. 82103477) and Medical Technology Innovation Fund of Chongqing General Hospital (Y2020ZDXM05).
Author information
Authors and Affiliations
Contributions
Conceptualization, F.Z. and Z-Y.Y.; original draft preparation, W-H.W. and Z-Y.Y.; editing and review, W-H.W., H-D.C., S-P.Y. and F.Z.; funding acquisition, Z-Y.Y. and F.Z. All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, W., Chen, H., Yin, S. et al. Targeting adipocyte–immune cell crosstalk to control breast cancer progression. J Cancer Res Clin Oncol 149, 7969–7979 (2023). https://doi.org/10.1007/s00432-023-04685-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-023-04685-3